Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bertagna

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 9, 2011
Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationSébastien Gaujoux, Frédérique Tissier, Bruno Ragazzon, et al.
Human Mutation|April 2, 2010
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an updateAnélia Horvath, Jérôme Bertherat, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patientsLionel Groussin, Gérald Bonardel, Stéphane Silvéra, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
The New England Journal of Medicine|November 29, 2013
Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasiaEstelle Louiset, Céline Duparc, Jacques Young, et al.
European Journal of Endocrinology|May 1, 2016
NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defectsFlorence Roucher-Boulez, Delphine Mallet-Motak, Dinane Samara-Boustani, et al.
The Lancet. Diabetes & Endocrinology|July 31, 2020
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phaseRosario Pivonello, Maria Fleseriu, John Newell-Price, et al.
The American Journal of Surgical Pathology|July 14, 2012
Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETEFrédérique Tissier, Sébastien Aubert, Emmanuelle Leteurtre, et al.
Plos One|August 5, 2014
IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinomaMarine Guillaud-Bataille, Bruno Ragazzon, Aurélien de Reyniès, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindredsLionel Groussin, Anelia Horvath, Eric Jullian, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|September 9, 2011
Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationSébastien Gaujoux, Frédérique Tissier, Bruno Ragazzon, et al.
Human Mutation|April 2, 2010
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an updateAnélia Horvath, Jérôme Bertherat, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patientsLionel Groussin, Gérald Bonardel, Stéphane Silvéra, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
The New England Journal of Medicine|November 29, 2013
Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasiaEstelle Louiset, Céline Duparc, Jacques Young, et al.
European Journal of Endocrinology|May 1, 2016
NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defectsFlorence Roucher-Boulez, Delphine Mallet-Motak, Dinane Samara-Boustani, et al.
The Lancet. Diabetes & Endocrinology|July 31, 2020
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phaseRosario Pivonello, Maria Fleseriu, John Newell-Price, et al.
The American Journal of Surgical Pathology|July 14, 2012
Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETEFrédérique Tissier, Sébastien Aubert, Emmanuelle Leteurtre, et al.
Plos One|August 5, 2014
IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinomaMarine Guillaud-Bataille, Bruno Ragazzon, Aurélien de Reyniès, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindredsLionel Groussin, Anelia Horvath, Eric Jullian, et al.
Pageof 13